Efficacy of metreleptin treatment in familial partial lipodystrophy due to PPARG versus LMNA pathogenic variants
March 12, 2019 at 10:41 pm
Sekizkardes H, Cochran E, Malandrino
N, Garg
G and Brown RJThe Journal of Clinical Endocrinology & Metabolism
doi: 10.1210/jc.2018-02787
https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/jc.2018-02787/5371329